aspsirna3135 details

Purple = Wild vs mutant target sequence along with mutation information
Brown= Wild vs ASP-siRNA description along with positional differnece between two
Light pink= ASP siRNA efficacy for mutant vs wild allele
Green= Wild siRNA efficacy for Wild vs Mutant allele
siRNA Id:aspsirna3135
siRNA Name: siRNA-T2
Gene:tumor protein p63 (TP63)
Disease:Ectrodactily-ectodermal dysplasia and cleft lip/palate (EEC)
Wild allele/target (5'->3'): CCGGAUCUGUGCUUGCCCA
Mutant allele/target (5'->3'):CUGGAUCUGUGCUUGCCCA
Target Mutation: c.727C>T, p.Arg243Trp
Wild siRNA (As strand):GGCCUAGACACGAACGGGU
ASP-siRNA (As strand):GACCUAGACACGAACGGGU
Mismatch position in siRNA: A18G
Mutant allele (5'->3'): CUGGAUCUGUGCUUGCCCA
ASP-siRNA (As strand):GACCUAGACACGAACGGGU
ASP-siRNA efficacy for mutant allele:85
Wild allele (5'->3'): CCGGAUCUGUGCUUGCCCA
ASP-siRNA (As strand):GACCUAGACACGAACGGGU
ASP-siRNA efficacy for wild allele:93
Percentage discrimination for ASP-siRNA:-8
Wild allele (5'->3'): CCGGAUCUGUGCUUGCCCA
Wild siRNA (As strand):GGCCUAGACACGAACGGGU
Wild sirna efficacy for wild allele:60
Wild allele (5'->3'): CCGGAUCUGUGCUUGCCCA
ASP-siRNA (As strand):GACCUAGACACGAACGGGU
Wild sirna efficacy for mutant allele:70
Percentage discrimination for wild siRNA:-10
Concentration:40 nM
Orientation:Sense
Mismatch in:siRNA
UniProt ID: Q9H3D4
Target sequence: TCCTGGGCCGACGCTGCTTTGAGGCCCGGATCTGTGCTTGCCC
Genbank Accesion: NM_001114980
Cell-line: HEK-293E
Experimental technique used: Dual luciferase reporter assay
Transfection method: Lipofectamine 2000
siRNA expression method: Chemically synthesized
Post-transfection duration: 48 hours
OMID ID: 604292
KEGG disease ID:NA
Reference:27195674

.
.
.
.
.
.
.
.
.
.
.

.

.

.